Medindia

X

West to Host 2009 Third Quarter Conference Call

Wednesday, October 28, 2009 General News J E 4
Advertisement


LIONVILLE, Pa., Oct. 27 West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release 2009 third quarter financial results before the market opens on Tuesday, November 3, 2009 and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call please dial 210-839-8398 or 888-790-3758. The passcode is WST.

A live broadcast of the conference call will be available at the Company's web site, www.westpharma.com, in the "Investor" section. Please allow extra time prior to the call to visit the site and download the streaming media software required to listen to the Internet broadcast.

An online archive of the broadcast will be available at the site two hours after the live call and will be available through Tuesday, November 17, 2009, by dialing 866-346-1326 or 203-369-0000 and entering conference ID# 4311.

About West

West is a global manufacturer of components and systems for injectable drug delivery, including stoppers and seals for vials, and closures and disposable components used in syringe, IV and blood collection systems. The Company also provides products with application to the personal care, food and beverage markets. Headquartered in Lionville, Pennsylvania, West supports its partners and customers from 50 locations throughout North America, South America, Europe, Mexico, Japan, Asia and Australia. For more information, visit West at www.westpharma.com.

Contacts: Investors and Financial Media: --------- ------------------------------ West FD Michael A. Anderson Evan Smith / Matthew Duch Vice President and Treasurer (212) 850-5600 (610) 594-3345 wst@fd.com

SOURCE West Pharmaceutical Services, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Inverness Medical Innovations Announces Third Quar...
S
Intercept Pharmaceuticals Announces Positive Phase...